Michael Hudecek MD

Michael Hudecek, MD performed medical training at the University of Leipzig, Germany. In his thesis, he analyzed the role of minor histocompatibility antigens during the graft-versus-leukemia response after allogeneic hematopoietic stem cell transplantation. Michael was recruited to the Fred Hutchinson Cancer Research Center in Seattle, WA in 2007 to perform a post-doctoral fellowship in the laboratory of Stanley R. Riddell.

In Seattle, Michael focused on rationally designing chimeric antigen receptors (CARs) and defining optimal cellular compositions of CAR-T cell products. Since 2012, Michael is leading an independent translational research laboratory at the Universitatsklinikum Wurzburg, Germany. Michael is an Extraordinary Member of the Bavarian Academy of Sciences, and was awarded the Artur-Pappenheim Preis of the German Society for Hematology and Medical Oncology in 2017.